Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-announces-first-patient-dosed-in-us-in-phase-1-study-for-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302343020.html
10 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-raises-16-million-in-series-b-financing-to-advance-lead-asset-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302326459.html
21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-ceo-speaks-at-fda-and-nih-public-meeting-to-encourage-innovation-of-smoking-cessation-treatment-options-302280571.html
01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/qnovia-inc-announces-fda-clearance-of-ind-application-for-lead-asset-respirx-nicotine-inhaler-as-a-prescription-smoking-cessation-therapy-302263046.html
08 Aug 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/developers-vapes-migraine-asthma-will-need-win-over-sceptics-2024-08-09/
09 Apr 2024
// BUSINESSWIRE
ABOUT THIS PAGE